News & Events

PACE® Genotyping and New Advances in Waxy Sorghum Breeding

PACE® Genotyping and New Advances in Waxy Sorghum Breeding

A new study from researchers at IGCAST Texas Tech University, University of Nevada and others has showcased how 3CR’s patented PACE® technology is driving innovation in sorghum breeding. By enabling the first functional markers for the waxy (Wx) trait, PACE® is helping researchers and seed companies accelerate the development of climate-smart, high-value sorghum varieties.

Why waxy sorghum matters

Sorghum is already one of the world’s most important grain crops, valued for its resilience in hot, dry, low-input environments. The “waxy” trait, caused by mutations in the Waxy (Wx) gene, leads to a starch composition with very low amylose and very high amylopectin. This change in starch structure creates significant commercial advantages:

  • Food & beverage: Waxy sorghum is gluten-free, improves baking functionality and is increasingly sought after in brewing and distilling as an alternative to barley.
  • Animal feed: The trait improves grain digestibility, translating into better feed efficiency.
  • Biofuels: Higher amylopectin content enables faster fermentation, improving ethanol yields.

With global specialty and ancient grain markets forecast to reach $3.8 billion by 2030, demand for waxy sorghum is set to rise. But until now, the tools to breed it efficiently have lagged behind.

The breeding challenge

Traditionally, breeders have relied on low-throughput PCR markers to identify Waxy alleles (wxaand wxb). These methods are incompatible with today’s large-scale genomic selection strategies, where thousands of plants are genotyped early in breeding cycles. The result has been a bottleneck: waxy sorghum was attractive on paper but slow to develop commercially.

How PACE® made the difference

The new study developed and validated PACE® PCR markers for the key Waxy alleles — wild-type (Wx), wxa, and wxb. These markers were tested across three independent breeding programs (University of Nevada, USDA-ARS and Richardson Seeds/Nuseed), proving reliable across diverse germplasm.

Key findings:

  • High accuracy: PACE® markers cleanly separated wild-type, wxa, and wxb genotypes.
  • Fast & scalable: Compatible with standard qPCR platforms, PACE® provided rapid, high-throughput results — a major improvement over traditional PCR assays.
  • Quality control: The assays detected off-types and cross-pollination events that are invisible to the naked eye, providing a vital safeguard for breeders advancing lines toward commercialisation.
  • Multiplex potential: Because PACE® can be multiplexed, Waxy markers can be run alongside genome-wide marker panels, streamlining breeding pipelines by collapsing multiple genotyping steps into one.

One of the key finds in this study was showing that PACE® is not limited to single nucleotide polymorphisms. The wxa allele of the Wx gene is a large InDel (Insertion/Deletion) – a 6 kb transposable element insertion in the first intron. Variants of this size are difficult to assay with standard PCR approaches.

The genetic architecture of the three alleles at the sorghum Waxy locus including the site of the full-length insertion responsible for the wxa allele and the SNP (G to T) for the wxb allele. From Yerka et al., 2025,

To overcome this, the researchers designed allele-specific PACE® assays that leverage the unique sequence differences between Wx, wxa, and wxb.

From the paper: We designed allele-specific PACE markers based on genetic variations between Wx, wxa, and wxb alleles. These PACE markers provided excellent discrimination of Wx, wxa, and wxb alleles. As the wxa allele includes a large insertion, we designed a common primer downstream of the insertion. The forward primer for wild-type (Wx) allele amplification is positioned upstream of the insertion while the forward primer for the wxa allele amplification is located at the end of the insertion. The expected amplicon sizes for PACE-PCR are 138 bp for Wx and 120 bp for wxa. Even though the forward primer for Wx can bind to the wxa DNA template in theory, the distance between the Wx and the common primer when the wxa insertion is present exceeds 5 kb, which is beyond the amplification range of PACE-PCR. This distinction enables differentiation between the two genotypes.

By developing a PACE® assay that cleanly distinguishes the wxainsertion alongside the more conventional wxb SNP allele, researchers demonstrated the versatility of the platform. PACE® can reliably genotype both SNPs and large InDels, giving breeders a practical way to track all major functional Waxy alleles in diverse germplasm. This capability not only accelerates waxy sorghum improvement but also highlights the broader potential of PACE® for crops where structural variants play an important role in trait expression.

PACE genotyping results generated for the three breeding programs, showing both homozygotes and heterozygotes for the wxaand wxbmarkers. From Yerka et al., 2025.

A stronger foundation for genomics-assisted breeding

This new molecular toolkit gives breeders a more complete and efficient way to integrate the waxy trait into high-yielding commercial sorghum hybrids.

Market impact

The implications of this research are clear:

  • Faster product development: Breeders can now move promising waxy lines through the pipeline with confidence, reducing time and cost.
  • Expanded commercial use: Reliable PACE® markers unlock opportunities in brewing, baking, biofuels, and feed markets where quality traits are critical.
  • Climate resilience: Waxy sorghum offers a viable alternative to barley and maize in regions affected by heat and drought, supporting more sustainable agricultural systems.

PACE®: Making science affordable

This study demonstrates why leading academic, public and private breeding programs turn to PACE®: it delivers accuracy, throughput and affordability in one platform. By replacing costly, time-consuming assays, PACE® makes advanced molecular breeding accessible to programs of all sizes.

At 3CR, our mission is simple: Making science affordable. With PACE® now validated as a powerful tool for specialty trait breeding in crops like sorghum, we are proud to support researchers and companies working to deliver the next generation of climate-smart, value-added crops to global markets.

Access the full paper here.


Reference: Yerka, M.K., Liu, Z., Bean, S., Nigam, D., Hayes, C., Druetto, D., Krishnamoorthy, G., Meiwes, S., Cucit, G., Patil, G.B. and Jiao, Y., 2025. An updated molecular toolkit for genomics-assisted breeding of waxy sorghum [Sorghum bicolor (L.) Moench]. Journal of Applied Genetics, pp.1-15.

MORE POSTS

PACE® Genotyping and New Advances in Waxy Sorghum Breeding
PACE® Genotyping Drives Precision Breeding in Cranberry’s
3CR Bioscience 2025 Events Calendar
[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Stay up to date with all things 3CR. 

Sign up now to receive insights, updates 
and industry case studies. 

MEET OUR TEAM

Steve Asquith Managing Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John Holme Technical Director
John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base. During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Dr. Nisha JainOperations Director
Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP. Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.
Nazma Saffin General Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Jon Curtis Non-Executive Chair
After 8 years in The Royal Air Force, Jon moved to the Imperial Cancer Research Fund where he pioneered the use of ultra high-throughput genomic automation, capable of 46,000 PCRs per hour. In the 1990’s Jon joined GlaxoSmithKline, implementing a high-throughput genomics platform into their drug discovery pipeline. Whilst there he also developed acoustic mixing into compound management, becoming the gold standard across pharma. Jon developed the world’s first commercially viable 1536-well PCR plates, automated thermal & laser plate-sealer, plus automated liquid-handling & tip washing tools to reduce waste and costs. In 2002 Jon co-founded KBioscience with Phil Robinson, utilising ultra high-throughput PCR instrumentation & a suite of automation tools to create the company’s SNPline robotic platform, with a capacity of 250,000 PCRs/day. The business was underpinned by their ground-breaking patented genotyping chemistry, KASP™, which has over 10,000 scientific papers to date. In November 2022 Jon joined 3CR Bioscience acting as an advisor bringing his commercial and scientific experience to the company.